glutathione mutations in sclc patients

glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Differential KEAP1/NRF2 mediated signaling widens

Name: glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Differential KEAP1/NRF2 mediated signaling widens
Brand: mlbdaktechniek.nl
SKU: 15106403274
Price: 25.37 USD
Availability: InStock
Rating: 4.7119 (8 reviews)

Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Oncology Letters Unveiling the powerhouse: ASCL1 driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation Cancer & Metabolism Springer Nature Link Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Oxidative Stress and its Role in Carcinogenesis Cell Biochemistry and Biophysics Springer Nature Link

SKU: 15106403274 · From mlbdaktechniek.nl

4.7

USD25.37 USD49.37

Pay in 4 interest-free payments of $6.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Acta Physiol (Oxf)

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Antioxidants To minimize the negative effects of ROS generated by any pro-oxidant, endogenous defensive mechanisms called antioxidant defense (AD) system, which utilizes enzymatic and non-enzymatic mechanisms